ASTROTECH Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
ASTROTECH Corp (ASTC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 56.94 million shares for the 9-month period ending 2026-03-31, per its 10-Q/A filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-06
- ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 32.03M shares, a 18.63% increase year-over-year.
- ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 24.51M shares, a 1468.89% increase year-over-year.
- ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 401.00K shares, a 93.23% decline year-over-year.
- ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-06-30 was 11.29M shares, a 284.10% increase year-over-year.
- ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 45.77M shares, a 242.17% increase from fiscal 2024.
- ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 13.38M shares, a 334.35% increase from fiscal 2023.
- ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 3.08M shares, a 24.86% decline from fiscal 2022.
- ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 4.10M shares, a 3999.00% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | 32.03M shares derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-08-06 | 56.54M shares derived: sum of 2 quarters · filed 2026-08-06 | 56.94M shares 10-Q/A · filed 2026-08-06 | 68.22M shares derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | 24.51M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | 24.91M shares 10-Q · filed 2026-02-13 | 36.19M shares derived: sum of 3 quarters · filed 2026-02-13 | 63.19M shares derived: sum of 4 quarters · filed 2026-02-13 | |
| 2025-09-30 | 401.00K shares 10-Q · filed 2025-11-13 | 11.69M shares derived: sum of 2 quarters · filed 2025-11-13 | 38.69M shares derived: sum of 3 quarters · filed 2025-11-13 | 40.25M shares derived: sum of 4 quarters · filed 2025-11-13 | |
| 2025-06-30 | 11.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26 | 38.29M shares derived: sum of 2 quarters · filed 2025-09-26 | 39.85M shares derived: sum of 3 quarters · filed 2025-09-26 | 45.77M shares 10-K · filed 2025-09-26 | |
| 2025-03-31 | 27.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | 28.56M shares derived: sum of 2 quarters · filed 2025-05-14 | 34.49M shares 10-Q · filed 2025-05-14 | 37.43M shares derived: sum of 4 quarters · filed 2025-09-26 | |
| 2024-12-31 | 1.56M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-14 | 7.49M shares 10-Q · filed 2025-02-14 | 10.43M shares derived: sum of 3 quarters · filed 2025-09-26 | 20.82M shares derived: sum of 4 quarters · filed 2025-09-26 | |
| 2024-09-30 | 5.93M shares 10-Q · filed 2024-11-13 | 8.87M shares derived: sum of 2 quarters · filed 2025-09-26 | 19.26M shares derived: sum of 3 quarters · filed 2025-09-26 | 19.26M shares derived: sum of 4 quarters · filed 2025-09-26 | |
| 2024-06-30 | 2.94M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26 | 13.33M shares derived: sum of 2 quarters · filed 2025-09-26 | 13.33M shares derived: sum of 3 quarters · filed 2025-09-26 | 13.38M shares 10-K · filed 2025-09-26 | |
| 2024-03-31 | 10.39M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14 | 10.39M shares derived: sum of 2 quarters · filed 2024-05-14 | 10.44M shares 10-Q · filed 2024-05-14 | 13.52M shares derived: sum of 4 quarters · filed 2024-09-20 | |
| 2023-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | 46.00K shares 10-Q · filed 2024-02-13 | 3.12M shares derived: sum of 3 quarters · filed 2024-09-20 | 3.12M shares derived: sum of 4 quarters · filed 2024-09-20 | |
| 2023-09-30 | 46.00K shares 10-Q · filed 2023-11-13 | 3.12M shares derived: sum of 2 quarters · filed 2024-09-20 | 3.12M shares derived: sum of 3 quarters · filed 2024-09-20 | 3.05M shares derived: sum of 4 quarters · filed 2024-09-20 | |
| 2023-06-30 | 3.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-20 | 3.08M shares derived: sum of 2 quarters · filed 2024-09-20 | 3.01M shares derived: sum of 3 quarters · filed 2024-09-20 | 3.08M shares 10-K · filed 2024-09-20 | |
| 2023-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-12 | -69.59K shares derived: sum of 2 quarters · filed 2023-05-12 | 2.41K shares 10-Q · filed 2023-05-12 | 3.98M shares derived: sum of 4 quarters · filed 2023-09-28 | |
| 2022-12-31 | -69.59K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-13 | 2.41K shares 10-Q · filed 2023-02-13 | 3.98M shares derived: sum of 3 quarters · filed 2023-09-28 | ||
| 2022-09-30 | 72.00K shares 10-Q · filed 2022-11-14 | 4.05M shares derived: sum of 2 quarters · filed 2023-09-28 | |||
| 2022-06-30 | 3.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | 4.10M shares 10-K · filed 2023-09-28 | 122.00K shares 10-K · filed 2022-09-15 | ||
| 2022-03-31 | 122.00K shares 10-Q · filed 2022-05-13 | ||||
| 2021-06-30 | 100.00K shares 10-K · filed 2022-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |